$REVBJul 21, 2026, 4:05 PM ETAI processed
REVB grants 108,000 RSUs to three new hires under Nasdaq inducement rule
AI Summary
Revelation Biosciences (REVB) said its compensation committee approved 108,000 restricted stock units to three newly hired non-executive employees as inducement awards under Nasdaq Listing Rule 5635(c)(4). The RSUs vest over two years in equal quarterly installments (first vesting Oct 15, 2026; final vesting Jul 15, 2028) under the company's 2026 Inducement Plan and will convert into 108,000 shares as they vest.
Positives
- 108,000 RSUs granted to three newly hired non-executive employees
- Awards granted as material inducements under Nasdaq Listing Rule 5635(c)(4)
- Vesting schedule is short-term (two years, equal quarterly installments)
Negatives
- Grants will dilute existing shareholders by up to 108,000 shares as they vest
- Creates additional share-based compensation expense over the vesting period
- Press release does not disclose recipients' roles, compensation value, or exact dilution percentage